Cross Shawn 4
4 · Cyclo Therapeutics, Inc. · Filed Jun 5, 2024
Insider Transaction Report
Form 4
Cross Shawn
Director
Transactions
- Award
Common Stock
2024-06-03+8,887→ 81,493 total - Award
Stock Option (Right to Buy)
2024-06-03+15,562→ 15,562 totalExercise: $1.28Exp: 2034-06-03→ Common Stock (15,562 underlying)
Footnotes (2)
- [F1]Represents the grant of fully-vested shares of common stock that the Reporting Person elected to receive in lieu of cash compensation under the issuer's non-employee director compensation policy. Grant reflects director compensation for the first quarter of 2024. The number of shares received in lieu of cash was calculated based on the closing price of $1.28 per share of common stock on June 3, 2024.
- [F2]The option vests over a one year period in equal quarterly installments.